A Case Report of Rapidly Lethal Acute Respiratory Distress Syndrome Secondary to Coronavirus Disease 2019 Viral Pneumonia.
acute respiratory distress syndrome
berlin criteria
coronavirus disease (covid-19)
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
21 May 2020
21 May 2020
Historique:
entrez:
26
6
2020
pubmed:
26
6
2020
medline:
26
6
2020
Statut:
epublish
Résumé
As of April 2020, the coronavirus 2019 (COVID-19) pandemic has resulted in more than 210,000 deaths globally. The most common cause of death from COVID-19 is acute respiratory failure. We report the case of a 78-year-old female with a history of hypertension, cerebrovascular accident (CVA), type 2 diabetes mellitus, and sarcoidosis, who presented to the emergency department with one day of dyspnea. The patient experienced a rapid decline in respiratory function and was intubated in the intensive care unit (ICU), meeting the Berlin criteria for severe acute respiratory distress syndrome (ARDS). Chest radiography revealed diffuse bilateral coalescent opacities, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA swab test was positive for COVID-19. The patient experienced acute kidney injury with uptrending creatinine levels and remained lethargic and unresponsive throughout her ICU stay, suggestive of potential hypoxic brain injury. In light of the patient's poor clinical status, age, and significant comorbidities, prognosis was conveyed about medical futility and patient's family agreed to terminal extubation and the patient expired peacefully, exactly one week from hospital admission. This case report highlights the speed at which severe ARDS can present and contribute to end-organ dysfunction in COVID-19 patients.
Identifiants
pubmed: 32582489
doi: 10.7759/cureus.8228
pmc: PMC7306658
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e8228Informations de copyright
Copyright © 2020, Ng et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
JAMA Intern Med. 2020 Mar 13;:
pubmed: 32167524
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Intensive Care Med. 2012 Oct;38(10):1573-82
pubmed: 22926653
N Engl J Med. 2020 Jun 4;382(23):2268-2270
pubmed: 32294339
Chest. 2008 May;133(5):1120-7
pubmed: 18263687
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632